I70.744 Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of heel and midfoot

Name of the Condition

• Common Name: Left Leg Bypass Graft Atherosclerosis with Heel and Midfoot Ulceration
• Medical Term: Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of heel and midfoot
• ICD-10 Code: I70.744

Summary

Atherosclerosis of other type of bypass graft(s) of the left leg with ulceration of heel and midfoot refers to plaque buildup in bypass grafts used to restore blood flow to the left leg, specifically involving ulcerated areas on the heel and midfoot. This condition narrows the graft, reducing blood flow and potentially leading to complications like graft failure or limb ischemia.

Causes

Atherosclerosis in bypass grafts develops due to the accumulation of fatty deposits, cholesterol, and other substances within the graft walls. This process is often accelerated by factors like poor blood flow, graft material, or underlying vascular disease, leading to narrowing and reduced graft function over time.

Risk Factors

• Age (more common in older adults)
• History of atherosclerosis or vascular disease
• Smoking or tobacco use
• Diabetes
• Hypertension (high blood pressure)
• High cholesterol or triglyceride levels
• Sedentary lifestyle
• Obesity

Symptoms

• Leg pain during activity (claudication)
• Reduced pulse or blood flow in the left leg
• Skin changes (pale, cool, or shiny skin)
• Non-healing wounds or ulcers on the heel and midfoot
• Numbness or weakness in the left leg
• Graft-related complications (e.g., blockage or failure)

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., Doppler ultrasound, angiography), and assessment of ulceration. Healthcare providers may also review patient history, perform physical exams, and use non-invasive vascular tests to confirm graft narrowing and ulcer presence.

Treatment Options

Treatment focuses on improving blood flow, managing ulceration, and addressing underlying risk factors. Options may include medications (e.g., antiplatelet agents, statins), wound care, revascularization procedures (e.g., graft revision or angioplasty), and lifestyle modifications. Severe cases may require amputation.

Prognosis and Follow-Up

Prognosis depends on the extent of graft narrowing, ulcer severity, and response to treatment. Regular follow-up is essential to monitor graft function, ulcer healing, and manage risk factors. Early intervention improves outcomes and reduces complications.

Complications

• Graft failure or blockage
• Limb ischemia or gangrene
• Infection of ulcers
• Amputation
• Recurrent ulceration
• Reduced mobility or quality of life

Lifestyle & Prevention

• Quit smoking or avoid tobacco use
• Manage diabetes, hypertension, and cholesterol levels
• Maintain a balanced diet and regular exercise
• Practice proper foot care (e.g., inspecting for injuries, wearing appropriate footwear)
• Follow prescribed medications and treatment plans

When to Seek Professional Help

Seek immediate medical attention if you experience:

• Sudden severe leg pain
• Non-healing or worsening ulcers
• Signs of infection (e.g., redness, swelling, pus)
• Changes in skin color or temperature
• Numbness or weakness in the left leg

Tips for Medical Coders

Document the specific location of ulceration (heel and midfoot) and confirm the bypass graft type. Ensure clinical notes support the presence of ulceration and its anatomical site. Verify that the code aligns with the documented diagnosis and avoid using this code for ulcerations in other leg regions.